Business
HEALTH LOGIC INTERACTIVE ANNOUNCES THE CLOSING OF ITS SALE OF ITS WHOLLY OWNED SUBSIDIARY
HEALTH LOGIC INTERACTIVE ANNOUNCES THE CLOSING OF ITS SALE OF ITS WHOLLY OWNED SUBSIDIARY...
About this update from Health Logic Interactive Inc
[{"type":"text","content":"\n \n \n \n HEALTH LOGIC INTERACTIVE ANNOUNCES THE CLOSING OF ITS SALE OF ITS WHOLLY OWNED SUBSIDIARY\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n TSXV: CHIP.H\n \n \n CALGARY, AB,\n \n Dec. 22, 2021\n \n /CNW/ -\n \n Health Logic Interactive Inc\n \n . (\"\n \n Health Logic\n \n \" or the \"\n \n Company\n \n \") (TSXV: CHIP.H) (OTCPK: CHYPF) is pleased to announce that it has completed the previously announced sale of its wholly owned subsidiary, My Health Logic Inc., (\"\n \n My Health Logic\n \n \") to Marizyme, Inc. (\"\n \n Marizyme\n \n \"), a\n \n Nevada\n \n medical device company publicly-traded on the OTCQB (the \"\n \n Transaction\n \n \"). Under the terms of the Arrangement Agreement, Marizyme has received all of the issued and outstanding shares of My Health Logic in exchange for 4,600,000 shares of common stock of Marizyme (\"\n \n Marizyme Shares\n \n \"). As a result of the Transaction the Company has disposed of all or substantially all of its assets and My Health Logic has become a wholly-owned subsidiary of Marizyme.\n \n \n \n \n \n \n \n \n \n Marizyme has a robust IP portfolio for its medical device platform technologies. Its leading technology, DuraGraft®, is currently under pre-submission review with the United States Food and Drug Administration (\"\n \n FDA\n \n \"). DuraGraft® is approved in 34 countries and has already achieved initial commercial sales in\n \n Europe\n \n and\n \n Asia\n \n . Marizyme intends to pursue a listing on the NASDAQ Stock Market (\"\n \n NASDAQ\n \n \") within the next twelve months.\n \n \n The co-founders of My Health Logic:\n \n Braeden Lichti\n \n ,\n \n George Kovalyov\n \n , and\n \n Harrison Ross\n \n (the \"\n \n Co-Founders\n \n \") commented \"As a team, and with the sale of My Health Logic, we were able to receive a return of just over 77% on our latest financing. We congratulate the founding scientific members and our co-managers in working together to close this transaction in a timely manner. We are looking forward to being a part o...